Phibro Animal Health Corp (PAHC) Insider Jack Bendheim Sells 30,000 Shares

Phibro Animal Health Corp (NASDAQ:PAHC) insider Jack Bendheim sold 30,000 shares of the stock in a transaction that occurred on Wednesday, June 13th. The shares were sold at an average price of $46.44, for a total value of $1,393,200.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Jack Bendheim also recently made the following trade(s):

  • On Monday, June 11th, Jack Bendheim sold 10,000 shares of Phibro Animal Health stock. The shares were sold at an average price of $46.46, for a total value of $464,600.00.
  • On Thursday, June 7th, Jack Bendheim sold 10,000 shares of Phibro Animal Health stock. The shares were sold at an average price of $46.47, for a total value of $464,700.00.
  • On Tuesday, June 5th, Jack Bendheim sold 10,000 shares of Phibro Animal Health stock. The shares were sold at an average price of $45.87, for a total value of $458,700.00.
  • On Thursday, March 15th, Jack Bendheim sold 24,000 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.05, for a total value of $961,200.00.

Shares of Phibro Animal Health traded up $0.30, hitting $46.80, during mid-day trading on Thursday, according to MarketBeat Ratings. 4,571 shares of the company were exchanged, compared to its average volume of 100,666. The company has a debt-to-equity ratio of 1.61, a current ratio of 3.17 and a quick ratio of 1.73. Phibro Animal Health Corp has a 1-year low of $32.05 and a 1-year high of $48.40. The company has a market cap of $1.89 billion, a PE ratio of 30.93, a P/E/G ratio of 2.78 and a beta of 0.94.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Monday, May 7th. The company reported $0.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.44 by $0.02. Phibro Animal Health had a return on equity of 39.91% and a net margin of 7.24%. The firm had revenue of $209.00 million during the quarter, compared to the consensus estimate of $203.03 million. During the same period last year, the company earned $0.37 earnings per share. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. analysts anticipate that Phibro Animal Health Corp will post 1.71 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 27th. Investors of record on Wednesday, June 6th will be issued a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 0.85%. The ex-dividend date is Tuesday, June 5th. Phibro Animal Health’s dividend payout ratio is presently 26.49%.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. lifted its holdings in shares of Phibro Animal Health by 17.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 476,391 shares of the company’s stock worth $15,959,000 after purchasing an additional 69,063 shares during the period. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Phibro Animal Health by 37.4% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 243,550 shares of the company’s stock worth $8,159,000 after purchasing an additional 66,300 shares during the period. Investors Research Corp acquired a new stake in shares of Phibro Animal Health during the fourth quarter worth $433,000. Prudential Financial Inc. lifted its holdings in Phibro Animal Health by 37.7% in the first quarter. Prudential Financial Inc. now owns 189,070 shares of the company’s stock valued at $7,506,000 after acquiring an additional 51,800 shares during the period. Finally, Arizona State Retirement System lifted its holdings in Phibro Animal Health by 229.1% in the fourth quarter. Arizona State Retirement System now owns 32,914 shares of the company’s stock valued at $1,103,000 after acquiring an additional 22,914 shares during the period. 48.82% of the stock is owned by hedge funds and other institutional investors.

Several research firms have recently weighed in on PAHC. Zacks Investment Research downgraded Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Thursday, May 10th. Credit Suisse Group increased their price target on Phibro Animal Health from $39.00 to $42.00 and gave the stock a “neutral” rating in a report on Wednesday, May 9th. BidaskClub raised Phibro Animal Health from a “sell” rating to a “hold” rating in a report on Wednesday, April 18th. Finally, ValuEngine raised Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Wednesday, February 28th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $38.80.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Insider Buying and Selling by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit